Relationship Between the Severity of Coronary Artery Disease and Renal Function

Metin Karayakali1, Hasan Kadi2, Kayıhan Karaman1

  • 1Department of Cardiology, Tokat Gaziosmanpasa University Hospital, Turkey.

Angiology
|January 31, 2026
PubMed

Insights

Estimated glomerular filtration rate (eGFR) is linked to coronary atherosclerosis. Declining eGFR significantly increases the risk of severe coronary artery disease, underscoring the importance of kidney function in cardiovascular health.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Estimated glomerular filtration rate (eGFR) is a recognized component of cardiovascular risk assessment.
  • The anatomical basis of this risk, specifically coronary atherosclerotic burden, is not well-characterized across the spectrum of renal function.

Purpose of the Study:

  • To investigate the association between eGFR and coronary atherosclerotic burden.
  • To provide anatomical validation for the inclusion of eGFR in cardiovascular risk prediction models.

Main Methods:

  • Retrospective analysis of 1181 patients undergoing elective coronary angiography.
  • Patients stratified into groups based on eGFR levels (≥90, 60-89, and 30-59 mL/min/1.73 m²).
  • Coronary atherosclerotic burden quantified using the Gensini score.

Main Results:

  • A significant inverse correlation was observed between eGFR and Gensini score (ρ = -0.352, P < .001).
  • Each 10 mL/min/1.73 m² decline in eGFR was associated with a 40% increased odds of severe coronary atherosclerosis (OR = 0.960, P < .001).
  • Patients with eGFR 30-59 mL/min/1.73 m² had a 6-fold higher odds of severe coronary atherosclerosis compared to those with preserved renal function (OR = 6.073, P < .001), independent of traditional risk factors.

Conclusions:

  • The study provides angiographic evidence linking reduced eGFR to increased coronary atherosclerotic burden.
  • Even mild renal dysfunction is associated with a higher atherosclerotic burden, reinforcing the cardiovascular-kidney-metabolic health continuum.
  • Findings support aggressive cardiovascular risk modification strategies in patients with declining renal function, especially diabetic women.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
443
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
372
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
687
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
378